(19)
(11) EP 4 065 166 A1

(12)

(43) Date of publication:
05.10.2022 Bulletin 2022/40

(21) Application number: 20894297.9

(22) Date of filing: 24.11.2020
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
A61K 47/18(2017.01)
A61K 47/12(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/395; A61K 47/12; A61K 47/18; C07K 16/241; C07K 16/32; C07K 16/22; C07K 16/4291; A61K 9/0019; A61K 47/10; A61K 47/22
(86) International application number:
PCT/US2020/062051
(87) International publication number:
WO 2021/108427 (03.06.2021 Gazette 2021/22)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 26.11.2019 US 201962940683 P

(71) Applicant: Comera Life Sciences, Inc.
Woburn, MA 01801 (US)

(72) Inventors:
  • SOANE, David, S.
    Palm Beach, FL 33480 (US)
  • WUTHRICH, Philip
    Watertown, MA 02472 (US)
  • MAHONEY, Robert, P.
    Newbury, MA 01922 (US)
  • ZENG, Yuhong
    Lexington, MA 02420 (US)
  • NAIK, Subhashchandra
    Watertown, MA 02472 (US)
  • TRAN, Timothy
    Medford, MA 02155 (US)

(74) Representative: Snaith, James Michael et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS